Endurant Capital Management LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Endurant Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $2.27 Million - $3.02 Million	-244,125 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $2.54 Million - $3.7 Million	244,125 New	244,125 $2.87 Million
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $2.23 Million - $3.2 Million	-133,648 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $239,286 - $341,953	16,168 Added 13.76%	133,648 $2.36 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $1.79 Million - $3 Million	117,480 New	117,480 $1.8 Million

164

40.6M

186K

157K

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $636M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.